Search Results

Filter
  • 1-10 of  756 results for ""Botulinum Toxins, Type A""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Intravesical Injection of OnabotulinumtoxinA (Botulinum Toxin Type A) in Japanese Patients With Refractory Overactive Bladder.

  • Authors : Gotoh D; Department of Urology, Nara Medical University, Kashihara, Japan.; Torimoto K

Subjects: Urinary Bladder, Overactive*/Urinary Bladder, Overactive*/Urinary Bladder, Overactive*/drug therapy ; Botulinum Toxins, Type A*/Botulinum Toxins, Type A*/Botulinum Toxins, Type A*/administration & dosage ; Botulinum Toxins, Type A*/Botulinum Toxins, Type A*/Botulinum Toxins, Type A*/adverse effects

  • Source: In vivo (Athens, Greece) [In Vivo] 2024 May-Jun; Vol. 38 (3), pp. 1332-1337.Publisher: International Institute of Anticancer Research Country of Publication: Greece NLM ID: 8806809 Publication Model: Print Cited Medium: Internet

Record details

×
Academic Journal

Investigation of intradetrusor onabotulinum toxin A efficacy and safety in older adults with urge urinary incontinence.

  • Authors : Basin MF; Department of Urology, SUNY Upstate University Hospital, Syracuse, NY, USA. .; Chadha P

Subjects: Neuromuscular Agents* ; Botulinum Toxins, Type A*/Botulinum Toxins, Type A*/Botulinum Toxins, Type A*/adverse effects ; Urinary Bladder, Overactive*/Urinary Bladder, Overactive*/Urinary Bladder, Overactive*/diagnosis

  • Source: International urology and nephrology [Int Urol Nephrol] 2024 May; Vol. 56 (5), pp. 1559-1563. Date of Electronic Publication: 2023 Dec 10.Publisher: Springer Country of Publication: Netherlands NLM ID: 0262521 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Shifts in patient preference of third-line overactive bladder therapy after introduction of the implantable tibial nerve stimulator.

Subjects: Urinary Bladder, Overactive*/Urinary Bladder, Overactive*/Urinary Bladder, Overactive*/therapy ; Electric Stimulation Therapy* ; Botulinum Toxins, Type A*/Botulinum Toxins, Type A*/Botulinum Toxins, Type A*/therapeutic use

  • Source: Neurourology and urodynamics [Neurourol Urodyn] 2024 Apr; Vol. 43 (4), pp. 959-966. Date of Electronic Publication: 2024 Feb 23.Publisher: Alan R. Liss Country of Publication: United States NLM ID: 8303326 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

How to define failure of intradetrusor injections of botulinum toxin A for neurogenic detrusor overactivity.

  • Authors : Mailho C; Department of Urology, Renal Transplantation and Andrology, Rangueil University Hospital, Toulouse, France.; Peyronnet B

Subjects: Botulinum Toxins, Type A*/Botulinum Toxins, Type A*/Botulinum Toxins, Type A*/therapeutic use ; Urinary Bladder, Neurogenic*/Urinary Bladder, Neurogenic*/Urinary Bladder, Neurogenic*/etiology ; Urinary Bladder, Overactive*/Urinary Bladder, Overactive*/Urinary Bladder, Overactive*/drug therapy

  • Source: Neurourology and urodynamics [Neurourol Urodyn] 2024 Apr; Vol. 43 (4), pp. 811-817. Date of Electronic Publication: 2024 Mar 07.Publisher: Alan R. Liss Country of Publication: United States NLM ID: 8303326 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Pain Related to Intradetrusor BotulinumtoxinA: A Randomized Clinical Trial.

  • Authors : Miceli LM; From the Division of Female Pelvic Medicine and Reconstructive Surgery, Houston Methodist Department of Obstetrics and Gynecology.; Antosh DD

Subjects: Urinary Bladder, Overactive*/Urinary Bladder, Overactive*/Urinary Bladder, Overactive*/drug therapy ; Botulinum Toxins, Type A*/Botulinum Toxins, Type A*/Botulinum Toxins, Type A*/adverse effects; Humans

  • Source: Urogynecology (Philadelphia, Pa.) [Urogynecology (Phila)] 2024 Mar 01; Vol. 30 (3), pp. 337-344.Publisher: Wolters Kluwer Health, Inc Country of Publication: United States NLM ID: 9918452588006676 Publication Model: Print Cited Medium: Internet

Record details

×
Academic Journal

Real-Life Treatment Outcome of Botulinum Toxin A Injection on Overactive Bladder and Voiding Dysfunction in Patients with Central Nervous System Lesions.

  • Authors : Jiang YH; Department of Urology, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Tzu Chi University, Hualien 970, Taiwan.; Jhang JF

Subjects: Urinary Bladder, Overactive* ; Botulinum Toxins, Type A* ; Parkinson Disease*

  • Source: Toxins [Toxins (Basel)] 2024 Mar 01; Vol. 16 (3). Date of Electronic Publication: 2024 Mar 01.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101530765 Publication Model: Electronic Cited Medium: Internet ISSN: 2072-6651

Record details

×
Academic Journal

Who Progresses to Third-Line Therapies for Overactive Bladder? Trends From the AQUA Registry.

  • Authors : Jericevic D; Department of Urology, New York University Langone, New York, New York.; Shapiro K

Subjects: Urinary Bladder, Overactive*/Urinary Bladder, Overactive*/Urinary Bladder, Overactive*/drug therapy ; Electric Stimulation Therapy*/Electric Stimulation Therapy*/Electric Stimulation Therapy*/methods ; Botulinum Toxins, Type A*/Botulinum Toxins, Type A*/Botulinum Toxins, Type A*/therapeutic use

  • Source: Urology practice [Urol Pract] 2024 Mar; Vol. 11 (2), pp. 394-401. Date of Electronic Publication: 2024 Jan 12.Publisher: Wolters Kluwer Country of Publication: United States NLM ID: 101635343 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Anatomical location and number of injection sites of intravesical OnabotulinumtoxinA for females with refractory idiopathic overactive bladder: A scoping review.

  • Authors : Kelsey E; Department of Urological Surgery, Barwon Health, University Hospital Geelong, Geelong, Victoria, Australia.; Wynn J

Subjects: Botulinum Toxins, Type A*/Botulinum Toxins, Type A*/Botulinum Toxins, Type A*/therapeutic use ; Urinary Bladder, Overactive*/Urinary Bladder, Overactive*/Urinary Bladder, Overactive*/drug therapy ; Urinary Bladder, Overactive*/Urinary Bladder, Overactive*/Urinary Bladder, Overactive*/chemically induced

  • Source: Neurourology and urodynamics [Neurourol Urodyn] 2024 Mar; Vol. 43 (3), pp. 553-564. Date of Electronic Publication: 2024 Jan 15.Publisher: Alan R. Liss Country of Publication: United States NLM ID: 8303326 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Real-world onabotulinumtoxinA treatment patterns in patients with overactive bladder.

  • Authors : Chughtai B; Department of Urology, Weill Cornell Medicine, New York, New York, USA.; Ricker CN

Subjects: Urinary Bladder, Overactive*/Urinary Bladder, Overactive*/Urinary Bladder, Overactive*/diagnosis ; Botulinum Toxins, Type A*; Female

  • Source: Neurourology and urodynamics [Neurourol Urodyn] 2024 Feb; Vol. 43 (2), pp. 396-406. Date of Electronic Publication: 2023 Dec 27.Publisher: Alan R. Liss Country of Publication: United States NLM ID: 8303326 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Antibiotic use, best practice statement adherence, and UTI rate for intradetrusor onabotulinumtoxin-A injection for overactive bladder: A multi-institutional collaboration from the SUFU Research Network (SURN).

  • Authors : Shapiro K; Department of Urology, New York University, New York City, New York, USA.; Anger J

Subjects: Urinary Bladder, Overactive*/Urinary Bladder, Overactive*/Urinary Bladder, Overactive*/drug therapy ; Urinary Bladder, Overactive*/Urinary Bladder, Overactive*/Urinary Bladder, Overactive*/complications ; Urinary Tract Infections*/Urinary Tract Infections*/Urinary Tract Infections*/drug therapy

  • Source: Neurourology and urodynamics [Neurourol Urodyn] 2024 Feb; Vol. 43 (2), pp. 407-414. Date of Electronic Publication: 2023 Nov 30.Publisher: Alan R. Liss Country of Publication: United States NLM ID: 8303326 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
  • 1-10 of  756 results for ""Botulinum Toxins, Type A""